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 Abstract  44 
The cytoskeletal protein filamin A (FLNA) has been suggested to play an important role in the 45 
responsiveness of GH-secreting pituitary tumors to somatostatin receptor subtype 2 (SSTR2) 46 
agonists, by regulating SSTR2 expression and signaling. However, the underlying mechanisms 47 
are unknown. Here, we use fast multi-color single-molecule microscopy to image individual 48 
SSTR2 and FLNA molecules at the surface of living cells with unprecedented spatiotemporal 49 
resolution. We find that SSTR2 and FLNA undergo transient interactions, which occur 50 
preferentially along actin fibers and contribute to restraining SSTR2 diffusion. Agonist 51 
stimulation increases the localization of SSTR2 along actin fibers and, subsequently, SSTR2 52 
clustering and recruitment to clathrin-coated pits (CCPs). Interfering with FLNA−SSTR2 binding 53 
with a dominant-negative FLNA fragment increases SSTR2 mobility, hampers the formation and 54 
alignment of SSTR2 clusters along actin fibers, and impairs both SSTR2 recruitment to CCPs 55 
and SSTR2 internalization. These findings indicate that dynamic SSTR2−FLNA interactions 56 
critically control the nanoscale localization of SSTR2 at the plasma membrane and are required 57 
for coupling SST2R clustering to internalization. These mechanisms explain the critical role of 58 
FLNA in the control of SST2R expression and signaling and suggest the possibility of targeting 59 
SSTR2−FLNA interactions for the therapy of pharmacologically resistant GH-secreting pituitary 60 
tumors. 61 
Keywords: Scaffolding proteins; cytoskeleton; GPCR endocytosis; TIRF microscopy 62 
 63 
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 1. Introduction 64 
Somatostatin (SS) is a peptide hormone that exerts key regulatory functions on the endocrine, 65 
neuronal and gastrointestinal systems. These actions are mediated by a family of five G-protein-66 
coupled receptors (GPCRs) known as SSTR1–5 (1, 2), and include inhibition of both cell 67 
proliferation and hormone secretion (3–6). Somatostatin receptor type 2 (SSTR2) − one of the 68 
most expressed receptor subtypes in GH-secreting pituitary adenomas − is the main target of 69 
somatostatin analogs (SSAs), which are widely used to treat acromegalic patients (7, 8). 70 
However, a relevant subset of patients is not successfully controlled by medical therapy with 71 
SSAs (9–11), and several studies have attempted to clarify the molecular mechanisms underlying 72 
the pharmacological resistance to SSAs (12–15). More recently, increasing attention has been 73 
directed towards the role of scaffolding proteins and cytoskeletal elements in mediating the 74 
formation of specialized signaling subdomains at the plasma membrane and facilitating receptor 75 
internalization (16–19). Thus, a better understanding of these mechanisms appears crucial to 76 
develop innovative pharmacological therapies for acromegaly and other human diseases. 77 
Filamin A (FLNA) is a large cytoskeletal protein characterized by an actin binding domain 78 
located at its N-terminus and multiple binding sites for molecules involved in different signaling 79 
pathways, which are distributed along the rest of its flexible structure. The primary function of 80 
FLNA is to cross-link actin filaments (F-actin) into a three-dimensional network that defines and 81 
controls cell shape. In addition, thanks to its ability to anchor transmembrane proteins to the actin 82 
cytoskeleton and its scaffolding role for intracellular proteins, FLNA is emerging as an important 83 
regulator of G-coupled receptor (GPCR) expression, subcellular localization, trafficking and 84 
signaling (20, 21). In particular, previous studies suggested that FLNA directly interacts with 85 
SSTR2 and that this interaction might be required for the SSTR2-mediated biological effects of 86 
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 SSAs (17, 22). However, how these interactions affect SSTR2 organization at the plasma 87 
membrane and its internalization was unknown. 88 
Here, we used innovative single-molecule imaging methods based on total internal reflection 89 
fluorescence (TIRF) microscopy (23-26) to investigate the involvement of FLNA in the spatial 90 
arrangement, mobility and internalization of SSTR2s with unprecedented spatio-temporal 91 
resolution. Our findings indicate that FLNA plays an important role in controlling the 92 
arrangement and mobility of SSTR2s at the plasma membrane by providing a physical link with 93 
actin fibers, which facilitates the clathrin-mediated internalization of SSTR2s.  94 
2. Materials and Methods 95 
Plasmids and constructs 96 
A plasmid encoding the human wild-type SSTR2 was kindly provided by Dr. Stefan Schulz. A 97 
plasmid encoding the SSTR2 with a FLAG sequence followed by a SNAP tag at its N-terminus 98 
(SNAP-SSTR2) was cloned by inserting the SSTR2 receptor sequence into a plasmid containing 99 
the SNAP tag directly after the FLAG sequence (23). A plasmid encoding FLNA with a CLIP tag 100 
inserted in its first hinge region (CLIP-FLNA) was generated by replacing eGFP with a CLIP tag 101 
in a construct coding for eGFP-FLNA (27), kindly provided by Dr. Anna M. Aragay. Plasmids 102 
expressing the FLNA repeats 19-20 or 17-18 (FLNA 19-20, FLNA 17-18) were previously 103 
described (17). A plasmid encoding eGFP-AP2 (28) was kindly provided by Dr. Emanuele 104 
Cocucci and Dr. Tom Kirchhausen. The plasmid coding for LifeAct-GFP (29) was kindly 105 
provided by Prof. Antje Gohla (Institute for Pharmacology and Toxicology, University of 106 
Würzburg). 107 
Cell culture  108 
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 Chinese hamster ovary K1 (CHO-K1) cells were maintained in Dulbecco's modified Eagle's 109 
medium/nutrient mixture F-12 (DMEM/F12) supplemented with 10% (v/v) fetal bovine serum 110 
(FBS), 100 U/ml penicillin and 100 µg streptomycin. Human embryonic kidney 293A 111 
(HEK293A) cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented 112 
with 10% (v/v) FBS, 2mM glutamine, 100 U/ml penicillin and 100 µg streptomycin. Cells were 113 
maintained in a humidified atmosphere of 5% CO2 at 37 °C. 114 
cAMP measurements  115 
To assess the functionality of the SNAP-SSTR2 construct, HEK293A cells were transiently 116 
cotransfected for 48 h with 1 μg of wild-type or SNAP-tagged SSTR2 and 1 μg of a fluorescence 117 
resonance energy transfer (FRET) sensor for cAMP (Epac1-camps) (30, 31) using the Effectene 118 
reagent (QIAgen, Hilden, Germany), and according to the instructions of the manufacturer. 119 
Ratiometric FRET measurements of intracellular cAMP levels, before and after incubation with 120 
increasing concentration of the selective SSTR2 agonist BIM23120 (Ypsen, Milan, IT), were 121 
performed on an Axiovert 200 inverted microscope (Zeiss; Jena, Germany), equipped with an oil-122 
immersion objective (plan-NEOFLUAR 63×/1.25), a 505 dcxr beam splitter (Visitron Systems; 123 
Puchheim, Germany), a high-speed polychromator system (Visitron Systems) and an iXon Ultra 124 
EMCCD camera (Andor; Belfast, UK) (32).  125 
Total Internal Reflection Fluorescence Microscopy 126 
For single-molecule experiments, CHO cells were seeded on 24-mm clean glass coverslips at a 127 
density of 3 × 105 cells per well, in complete phenol-red-free medium in order to minimize 128 
autofluorescence. On the following day, cells were transiently transfected with 2 μg DNA and 4-129 
6 μL of Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA), according to the 130 
manufacturer´s instructions. Cells were analyzed 4–12 h after transfection to achieve low 131 
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 expression levels. CHO cells, transfected with SNAP-SSTR2 and CLIP–FLNA were labeled with 132 
1 µM Alexa647-BG (Alexa Fluor 647-SNAP Surface; New England Biolabs, UK) and 1 133 
µMTMR-BC (CLIP-Cell TMR-Star; New England Biolabs, UK), respectively. Labeling was 134 
performed in complete phenol-red-free medium for 20 min at 37 °C 5% CO2. At the end of the 135 
incubation, cells were washed three times with complete phenol-red-free medium, each time 136 
followed by 5 min incubation at 37 °C, and immediately imaged. These conditions resulted in 137 
optimized labeling of cell-surface SNAP-tagged receptors and intracellular CLIP-FLNA 138 
particles. A custom total internal reflection fluorescence (TIRF) microscope based on an Eclipse 139 
Ti (Nikon) equipped with four EMCCD cameras (iXon DU897, Andor), 405 nm, 488 nm , 561 140 
nm and 640 nm diode lasers (Coherent), and a 100× oil-immersion objective (CFI Apo TIRF 141 
100x N.A. 1.49, Nikon) was used. Cells were first searched using bright field illumination and 142 
then a fine focus adjustment was performed switching to TIRF mode, always keeping the 143 
intensity of the laser power as low as possible (3% laser power). This procedure minimized 144 
photobleaching before image acquisition. Afterwards, laser power was set to 30% and image 145 
sequences (300–400 frames) were acquired with an exposure time of 30 ms, resulting in an 146 
interval between frames of 61.9 ms. The penetration depth of the evanescent field was ∼100 nm. 147 
The microscope was equipped with an incubator and a temperature control unit. Experiments 148 
were performed at 20.5 ± 0.3 °C. Only cells with less than 0.57 receptor particle/μm2 were 149 
analyzed.   150 
MSD analysis 151 
Single-molecule image sequences were analyzed as previously described (23–26), including 152 
automated single particle detection and tracking, which were performed using the utrack software 153 
in MATLAB (MathWorks) environment (33). Receptor diffusion was calculated on the basis of a 154 
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 mean square displacement (MSD) analysis of individual trajectories derived from TIRF image 155 
sequences as previously described (24). MSD data were fitted with the following equation:  156 
    (Eq. 1) 157 
where t indicates time and α is the anomalous diffusion exponent.  is the standard deviation of 158 
the localization error, which was estimated to be approximately 23 nm. Only trajectories lasting 159 
at least 70 frames were analyzed. Since this analysis revealed heterogeneity among particles, 160 
trajectories were then classified according to the diffusion parameters D and α. We considered 161 
particles with D < 0.01 µm2.s-1 to be confined. Particles with D ≥ 0.01 µm2.s-1 and 0.75 ≤ α ≤ 162 
1.25 were considered to have normal diffusion. Particles were considered to have sub- or super-163 
diffusion in case of D ≥ 0.01 µm2.s-1 and α <0.75 or α >1.25, respectively. 164 
Colocalization index analysis based on single-molecule localizations  165 
To analyze the relationship between localizations of SSTR2 obtained by single-molecule 166 
microscopy and the signals obtained in the actin channel, we adapted the method developed by 167 
Ibach et al. (34), as previously described (26). The method is based on a modification of 168 
Manders´ colocalization coefficients (35). Briefly, in our study, we generated a binary mask 169 
corresponding to the fibers the actin channel and we calculated the number of SSTR2 170 
localizations where the mask in the actin channel is equal to 1. This was used to calculate a 171 
colocalization index, whose values can range from -1 in case of perfect anti-correlation to +1 in 172 
case of perfect correlation/colocalization, whereas a value of 0 indicates no colocalization. 173 
Immunofluorescence and confocal fluorescence microscopy  174 
CHO cells were plated on 13-mm coverslips at a density of 1.5 × 105 cells per well in 24-well 175 
plates and grown at 37 °C for 18 h. Cells were then cotransfected with LifeAct-GFP, SNAP- 176 
 8 
 SSTR2 and FLNA17-18 or FLNA19-20. Receptors were labeled 24-48 h after transfection and 177 
stimulated with saturating concentration (100 nM) of BIM23120 up to 10 min to observe receptor 178 
clusters alignment with actin and colocalization with AP-2, for 15, 30, and 60 min to follow 179 
receptor internalization, at 37°C. After that, cells were fixed with 4% paraformaldehyde for 10 180 
min at room temperature, and washed three times in PBS. Cells cotransfected with SNAP-SSTR2 181 
and FLNA fragments only were permeabilized with 0.3% Triton X-100 in PBS for 5 min, 182 
incubated with 10% FBS in PBS (Thermofisher, Rockfor, IL) for 30 min and then incubated with 183 
anti AP-2 antibody (Thermofisher, Rockfor, IL) for 2 h at room temperature. After 3 washes with 184 
PBS containing 0.05% Tween 20, cells were stained with Alexa Fluor 488 conjugated secondary 185 
antibody (Thermofisher, Rockfor, IL) for 1 h at room temperature and extensively washed. Both 186 
primary and secondary antibodies were diluted in an antibody dilution buffer containing 1% 187 
BSA, 0.3% Triton X-100 in PBS. All coverslips were mounted on glass slides with ProLong 188 
Diamond Antifade mounting medium with 4',6-diamidino-2-phenylindole (DAPI) (Life 189 
Technologies, Carlsbad, CA). Image acquisition was performed on a Leica TCS SP2 laser 190 
scanning confocal microscope equipped with Ar 488 nm, HeNe 543 nm and 635 nm lines and a 191 
63× objective (HCX PL APO 63X/1.4-0.60 OIL) (Leica Microsystems, Wetzlar, Germany).  192 
Colocalization analysis based on confocal images 193 
For colocalization analysis based on confocal microscopy, confocal images in the different 194 
channels were acquired separately, upon adjusting the photomultiplier gain for each channel to 195 
minimize background noise and avoid saturated pixels. Only the optical section corresponding to 196 
the plasma membrane was analyzed. The degree of colocalization between SSTR2 and actin and 197 
between SSTR2 and AP-2 were measured on raw images, by calculating Pearson’s correlation 198 
coefficient (PCC) and Manders’ colocalization coefficients (MCC), respectively, with the JACoP 199 
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 tool in the NIH ImageJ software. SSTR2 clusters analysis was performed by including clusters of 200 
area between 0.01 and 0.3 μm2. 201 
Quantification of SSTR2 internalization  202 
To quantify SSTR2 internalization, about 8-12 equatorial confocal sections from each cell body 203 
were sequentially collected to ensure a scan thickness of ∼ 500 nm. The mean fluorescence 204 
density (F) in two distinct regions corresponding to the plasma membrane and the cytosol were 205 
determined densitometrically in one representative focal plane for each cell. The mean plasma 206 
membrane to cytosol fluorescence ratio (fR) was then calculated according to the following 207 
equation: fR = [F(membrane) - F(background)] / [F(total) - F(background)] with NIH ImageJ, as 208 
previously described (36). At least 30 cells for each group, from three independent transfections 209 
were analyzed, and results were plotted as mean value ± SEM expressed as % of basal condition.  210 
An assay based on reversible biotinylation of cell surface-proteins was used to quantify receptor 211 
internalization. CHO cells transiently expressing FLNA fragments and wild-type SSTR2 were 212 
washed three times with ice-cold PBS, followed by a 30-min incubation with 500 µg/ml 213 
cleavable EZ-Link sulfo-NHS-SS-biotin (Thermofisher, Rockfor, IL) at 4 °C. Unreacted biotin 214 
was blocked and removed by three washes with cold Tris-buffered saline containing 10 mM 215 
glycine. Biotinylated cells were incubated in pre-warmed medium with or without 100 nM 216 
BIM23120 at 37 °C for 30 min, and then chilled on ice to stop endocytosis. Glutathione (Sigma-217 
Aldrich, St. Louis, MO) was used to release the biotin label from proteins at the cell surface: cells 218 
were washed twice with cold glutathione strip buffer (50 mM glutathione, 75 mM NaCl, 75 mM 219 
NaOH, 10% FBS in H2O), at 4 °C for 20 min. Excess glutathione was then quenched by 30 min 220 
incubation with 50 mM iodoacetamide (Sigma-Aldrich, St. Louis, MO) in PBS, 1% BSA, pH 7.4 221 
at 4 °C. Cells were lysed with 35 µl lysis buffer (Cell Signaling Technology, Danvers, MA) and 222 
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 60 µg of total cellular protein extract was incubated with 1 μg SSTR2 (yI-17) antibody (Santa 223 
Cruz Biotechnology, Santa Cruz, CA) in a total volume of 100 µl of lysis buffer over night at 4 224 
°C on a rotating device, for immunoprecipitation. 20 µl of protein A/G Plus-Agarose (Santa Cruz 225 
Biotechnology, Santa Cruz, CA) was then added, and tubes were incubated for 3 h at 4 °C under 226 
constant rotation. After 5 washes with ice-cold PBS, the pellet was resuspended in 45 µl of Blue 227 
loading buffer (Cell Signaling Technology, Danvers, MA). Eluted proteins were separated by 228 
SDS-PAGE under nonreducing conditions. To detect biotinylated proteins, a 1:500 dilution of a 229 
horseradish peroxidase-linked antibody specific for biotin (Cell Signaling Technology, Danvers, 230 
MA) was used. The presence of equal receptor amounts in the immunoprecipitates was confirmed 231 
by stripping and reprobing with an antibody against SSTR2 (1:1000; UMB-1, Abcam, 232 
Cambridge, UK ) and using an anti-mouse secondary antibody covalently coupled to horseradish 233 
peroxidase (1:2000). The resulting bands were analyzed with the NIH ImageJ software. 234 
Experiments were performed in triplicate.  235 
Statistical analysis 236 
All statistical analyses were performed using the Prism 7 software (GraphPad, San Diego, CA). 237 
Unless otherwise stated, data were analyzed by two-tailed paired Student t test or Chi square test, 238 
as indicated. P < 0.05 was accepted as statistically significant. 239 
3. Results 240 
Single-molecule microscopy captures individual SSTR2 and FLNA molecules in living cells 241 
To visualize individual SSTR2 molecules at the plasma membrane of living cells, we generated a 242 
SSTR2 construct carrying a SNAP-tag at its N-terminus (SNAP-SSTR2) (37). The functional 243 
activity of SNAP-SSTR2 was confirmed by testing its ability to inhibit adenylyl cyclase activity 244 
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 in transfected HEK293A cells incubated with increasing concentrations of the selective SSTR2 245 
agonist BIM23120 (Figure 1A and Supplemental Fig. 1). To allow simultaneous imaging of 246 
SSTR2 and FLNA, we additionally generated a FLNA construct carrying a CLIP-tag within its 247 
first hinge region (CLIP-FLNA) (Figure 1B) (38). The CLIP-FLNA construct was validated in 248 
transfected CHO cells for its capacity to induce correct stress fibers organization and colocalize 249 
with actin filaments (Supplemental Fig. 2). These constructs were subsequently transiently 250 
transfected in CHO cells, covalently labeled with selective SNAP and/or CLIP fluorescent 251 
substrates and imaged by fast one- or two-color TIRF microscopy (Figure 1C, D). Individual 252 
SSTR2 and FLNA particles were then automatically detected and tracked using the utrack 253 
software (33) (Figure 1E, F, G, H).  254 
Single-molecule analysis of SSTR2 reveals heterogeneous receptor dynamics at the plasma 255 
membrane  256 
The spatio-temporal dynamics of SSTR2 at the plasma membrane of living cells was first 257 
analyzed in terms of receptor lateral mobility. To this end, CHO cells, which do not express 258 
endogenous SSTR2 (data not shown), were transiently transfected to express SNAP-SSTR2 at 259 
low physiological densities (0.57 ± 0.07 particle/µm2) and imaged by TIRF microscopy before 260 
and up to 5 min after stimulation with 100 nM of BIM23120. A mean-square displacement 261 
(MSD) analysis (23, 26) was used to estimate the diffusion coefficients of the SSTR2 particles 262 
based on their trajectories (Figure 2A and B). The results of this analysis revealed a high 263 
heterogeneity among SSTR2 particles, both under basal and stimulated conditions. The results of 264 
the MSD analysis were also used to classify the SSTR2 trajectories into four groups 265 
corresponding to receptors that were either virtually immobile or were characterized by a 266 
confined, directed or Brownian motion (sub-, super-, normal diffusion, respectively) (Figure 2A 267 
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 and C).  268 
Prior to stimulation, the mobile fraction was 94.6%. Short-term stimulation with BIM23120 269 
caused a statistically significant increase in the fraction of virtually immobile SSTR2s compared 270 
to basal conditions (16.5% vs. 5.4 %, respectively) and a corresponding reduction of around 3% 271 
for the remaining fractions (Figure 2C). This was accompanied by a general reduction of the 272 
average diffusion coefficient (D) values estimated for the three mobile fractions compared to 273 
basal conditions (from 0.062 to 0.077 µm2·s-1, from 0.099 to 0.114 µm2·s-1 and from 0.115 to 274 
0.130 µm2·s-1 for sub-, normal and super-diffusion fractions, respectively) (Figure 2D). 275 
To investigate the possible involvement of the cortical actin cytoskeleton in anchoring and/or 276 
limiting the mobility of SSTR2s (23, 26, 39), we simultaneously imaged actin fibers via co-277 
transfection of LifeAct-GFP (29) (Figure 2E). We found that SSTR2s were preferentially 278 
localized along actin fibers, as indicated by positive colocalization index values (for details about 279 
the analysis see ref. 26). The preferential localization of SSTR2s along actin filaments was 280 
further enhanced by BIM23120 stimulation (Figure 2F). These data suggested that SSTR2s were 281 
either directly or indirectly interacting with the underlying actin cytoskeleton. 282 
Filamin A controls SSTR2 mobility at the plasma membrane 283 
The subcortical cytoskeleton has been shown to provide anchor points for receptors and other 284 
membrane proteins as well as barriers to their diffusion – a concept known as the fence-and-285 
picket model (39), ultimately resulting in the formation of subdomains at the plasma membrane 286 
(26, 39). Since FLNA is a major actin binding protein and has been previously suggested to 287 
interact with SSTR2 based on in vitro results (17, 22), we investigated whether FLNA-SSTR2 288 
interactions occur in living cells and play a role in SSTR2 spatial arrangement and mobility.   289 
For this purpose, we co-expressed SNAP-SSTR2 and CLIP-FLNA in CHO cells at low 290 
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 physiological levels and simultaneously imaged individual SSTR2 and FLNA molecules by fast 291 
two-color TIRF microscopy followed by automated single particle tracking. In a subset of 292 
experiments, we additionally labeled actin fibers via co-transfection of LifeAct-GFP. Importantly, 293 
we observed individual SSTR2s transiently stopping at sites on actin fibers where a FLNA 294 
molecule was also located (Figure 3A and Supplemental Fig. S3, Supplemental Movie 1 and  295 
Supplemental Movie 2). These results revealed that SSTR2 undergo transient interactions with 296 
FLNA lasting approximately 0.521 seconds, which resulted in a preferential localization of 297 
SSTR2s along actin fibers.  298 
We then explored the overall contribution of SSTR2−FLNA interactions on SSTR2 mobility at 299 
the plasma membrane. In order to interfere with SSTR2−FLNA interactions, we co-expressed a 300 
FLNA fragment corresponding to domains 19 and 20 (FLNA 19-20), which has been previously 301 
suggested to exert a dominant negative effect on the binding of SSTR2 to endogenous FLNA 302 
(17). The FLNA fragment encompassing repeats 17 and 18 (FLNA 17-18) was used as control 303 
(17). Individual SSTR2 particles retained their heterogeneous diffusion dynamics, independently 304 
of the presence of the dominant negative fragment (FLNA 19-20), as shown by a MSD analysis 305 
(Figure 3B). However, the average diffusion coefficients measured with FLNA 19-20 under basal 306 
conditions were overall higher than with the control fragment (FLNA 17-18) and these 307 
differences reached statistical significance for the super-diffusing particles, suggesting that the 308 
previously observed dynamic SSTR2-FLNA interactions on acting fibers contributed to slowing 309 
down SSTR2 diffusion at the plasma membrane (Figure 3C). 310 
Disrupting SSTR2−FLNA interactions hampers agonist-dependent SSTR2 clustering 311 
Since interactions with the actin cytoskeleton have also been suggested to play a possible role in 312 
receptor clustering (40, 41), we simultaneously imaged SSTR2, FLNA and actin at later time 313 
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 points. TIRF images acquired in CHO cells stimulated with BIM23120 for 10 min showed the 314 
formation of SSTR2 clusters, which were absent under basal conditions (Figure 4A, arrowheads). 315 
Interestingly, we found that these clusters had a tendency to be aligned along actin fibers and that 316 
FLNA was often present together with SSTR2 in these clusters. Similar results were also 317 
obtained in confocal microscopy experiments (Figure 4B), in which we used higher SSTR2 and 318 
FLNA expression levels to facilitate the detection of the clusters. Co-expression of the dominant 319 
negative FLNA fragment (FLNA 19-20) caused a statistically significant reduction of the 320 
colocalization of SSTR2 clusters with actin (Figure 4B and C). This was accompanied by a 321 
statistically significant reduction in the size of SSTR2 clusters (Figure 4D) and a tendency 322 
towards a reduction of their number (Figure 4E). These findings indicate a role of FLNA in the 323 
formation and correct spatial arrangement of SSTR2 clusters along actin fibers. 324 
FLNA is required for efficient clathrin-mediated endocytosis of SSTR2  325 
Like for many other GPCRs, prolonged SSTR2 stimulation leads to its internalization, mainly via 326 
clathrin-mediated endocytosis (CME) (42, 43). Since actin and FLNA have been implicated in 327 
CME (40, 44–49), we investigated whether FLNA played a role in SSTR2 internalization. For 328 
this purpose, we simultaneously imaged the adaptor protein complex 2 (AP-2), which participates 329 
in both clathrin coated pit (CCP) initiation and recruitment of receptors to nascent CCPs, and is a 330 
widely used marker of CME (28). Confocal microscopy showed that, in cells expressing the 331 
FLNA17-18 control fragment and stimulated with BIM23120 for 10 min, a relevant fraction of 332 
SSTR2 clusters contained AP-2 (Figure 5A, white spots). These structures containing SSTR2s in 333 
nascent CCPs were observed to a remarkably lesser extent in FLNA 19-20 expressing cells 334 
(Figure 5A). Indeed, Manders’ coefficient analysis demonstrated that the degree of SSTR2 335 
colocalization with AP-2-positive pits (MCC1) was significantly reduced (from 37.1 ± 8.7% to 336 
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 18.9 ± 9.9%) in the presence of the dominant-negative FLNA19-20 fragment. This was 337 
accompanied by a similar reduction in the colocalization of AP2 with SSTR2 (MCC2; Figure 338 
5B). These data suggested that whereas interfering with SSTR2−FLNA interactions had 339 
significant but modest effects on the formation of SSTR2 clusters − consistent with the results of 340 
Figure 4B − it largely impaired their coupling to CCPs and, thus, the recruitment of SSTR2 to 341 
CCPs. 342 
Interfering with SSTR2−FLNA interactions impairs SSTR2 internalization 343 
Given our observation that FLNA is required for SSTR2 recruitment to CCPs, we further studied 344 
the impact of FLNA−SSTR2 interactions on SSTR2 internalization. For this purpose, we 345 
analyzed the subcellular localization of SSTR2 by confocal microscopy in CHO cells transiently 346 
cotransfected with SNAP-SSTR2 and either FLNA17-18 or FLNA19-20 fragments and incubated 347 
with or without the agonist BIM23120 for up to 60 min. Under basal conditions, SSTR2 was 348 
virtually exclusively located at the plasma membrane, both in the presence of FLNA17-18 and 349 
FLNA19-20. As expected, BIM23120 induced a robust, time-dependent internalization and 350 
accumulation of SSTR2 in vesicles scattered throughout the cytoplasm in the presence of the 351 
control FLNA17-18 fragment (amount of internalized receptor of 54.8%, 68.7% and 71.4% after 352 
15, 30 and 60 min, respectively, corresponding to a fR of 0.45, 0.31 and 0.27, respectively) 353 
(Figure 6A and B). In contrast, SSTR2 internalization was significantly impaired in the presence 354 
of the dominant negative FLNA19-20 fragment (amount of internalized receptor of  41.5%, 355 
45.4% and 53% after 15, 30 and 60 min, respectively, corresponding to a fR of 0.58, 0.55 and 356 
0.47, respectively) (Figure 6A and B).  357 
An assay based on biotinylation of cell-surface receptors further showed that SSTR2 358 
internalization was impaired in cells expressing the dominant negative FLNA19-20 fragment 359 
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 compared to cells expressing the control FLNA17-18 fragment (39.1 ± 6.7% vs. 9.0 ± 2.9%, 360 
respectively; *, P<0.01 vs. FLNA 17-18 expressing cells) (Figure 6C). 361 
4. Discussion 362 
The present study investigated the spatiotemporal dynamics of SSTR2 at the plasma membrane, 363 
revealing a crucial active role of the cytoskeletal adaptor protein FLNA in coordinating SSTR2 364 
diffusion dynamics and internalization. Our major findings suggest a model whereby FLNA 365 
molecules transiently interact with agonist-activated SSTR2s, facilitating their loose attachment 366 
to subcortical actin fibers and, thus, controlling their spatial arrangement and mobility. By 367 
controlling the localization of SSTR2s relative to the actin cytoskeleton, FLNA-SSTR2 368 
interactions promote SSTR2 internalization via facilitating the coupling between receptor 369 
clustering and accumulation in CCPs, both processes that occur with intervention of the actin 370 
cytoskeleton (45–49) (Figure 7).  371 
Our single-molecule data indicate that SSTR2 lateral diffusion is modulated by agonist 372 
stimulation. The very high percentage (94.6%) of the mobile fraction seen under basal conditions 373 
is in agreement with fluorescence recovery after photobleaching (FRAP) results obtained with 374 
murine SST2a in living hippocampal neurons (50). Interestingly, our data show a significant 375 
increase in the fraction of virtually immobile receptors and lower diffusion coefficients within the 376 
mobile fractions in stimulated CHO cells in comparison with the basal state. These findings 377 
indicate that only a minor fraction of SSTR2s is associated with the cytoskeleton in the resting 378 
state, whereas such cytoskeletal interactions occur more frequently when the receptors are 379 
activated (Figure 2). Few controversial data are present in the literature regarding the role of 380 
FLNA in regulating the diffusion of cell surface proteins (51, 52). Our MSD analysis shows that 381 
in the presence of FLNA19-20, used to interfere with SSTR2-FLNA interactions (17, 22), 382 
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 SSTR2s are more mobile compared to control cells (Figure 3). Overall, our findings are in 383 
agreement with the fence-and-picket model of the plasma membrane (53, 54), according to which 384 
integral membrane proteins (“pickets”) and barriers provided by the subcortical cytoskeleton 385 
(“fences”) compartmentalize the plasma membrane into small domains where receptors are 386 
loosely trapped. Our recently published data indicate that this phenomenon contributes to the 387 
formation of hot spots where receptors preferentially accumulate and signal (26). The findings of 388 
the present study suggest the FLNA might act as a scaffold to preferentially recruit ligand-389 
activated receptors at specific actin-rich regions of the plasma membrane, which, in turn, would 390 
facilitate SSTR2 recruitment in CCPs and their internalization. 391 
Previous studies have implicated the actin cytoskeleton in the maintenance of discrete sites of 392 
CCP assembling on the plasma membrane (44–49). When we investigated SSTR2 dynamics at 393 
higher receptor expression levels (obtained after 48 h transfection) than the ones achieved in 394 
previous single molecule experiments (obtained after 4-18 h transfection), we observed receptor 395 
clustering upon prolonged stimulation. However, both the colocalization between SSTR2 clusters 396 
and actin filaments and the size of SSTR2 clusters were significantly reduced in the presence of 397 
FLNA19-20, the dominant negative fragment of FLNA (Figure 4). These findings suggest that 398 
FLNA acts by linking SSTR2 clusters, CCPs and subcortical actin fibers. A similar clathrin−actin 399 
linking role has been previously suggested for other actin binding proteins such as the huntingtin-400 
interacting protein 1 related protein (Hip1R) (46). Among the different proteins that cooperate in 401 
the formation of CCPs, AP-2 is one of the key co-factors that promotes CCP initiation at the 402 
plasma membrane to then disengage from CCPs immediately before vesicle internalization (55). 403 
In particular, the association of membrane-bound AP-2 with cytosolic clathrin triskelions favors 404 
cargo protein capture by the activated µ2 subunit of AP-2 (28, 56). Intriguingly, our data indicate 405 
 18 
 that interfering with SSTR2-FLNA interactions reduces the colocalization between agonist-406 
induced SSTR2 clusters and AP2-containing CCPs, further supporting our hypothesis of a role 407 
for FLNA in the spatial coordination of receptor clustering and recruitment into nascent CCPs 408 
(Figure 5).  409 
It has been previously postulated that the actin cytoskeleton might also play a mechanical role in 410 
CME, providing the force to drive invagination and translocation of the nascent vesicles into the 411 
cytoplasm (57, 58). Our data suggest that interactions with FLNA are required to initiate and 412 
sustain the overall process of clathrin-dependent SSTR2 internalization (40, 41, 52, 59–64). Our 413 
imaging and biochemical data show that SSTR2 is rapidly and efficiently internalized in CHO 414 
cells (about 70% internalization after 30 min of agonist exposure), in agreement with previous 415 
observations (42, 65–67). However, SSTR2 internalization was strongly impaired when 416 
FLNA−SSTR2 association was inhibited (Figure 6). This is in accordance with our previous 417 
observation that FLNA−SSTR2 binding is not required for SSTR2 expression and 418 
membrane localization in GH-secreting tumor cells but is rather involved in SSTR2 signaling and 419 
downregulation (17). 420 
In conclusion, our findings reveal that SSTR2−FLNA undergo transient interactions in living 421 
cells, which dynamically link SSTR2s to the actin cytoskeleton. These interactions with FLNA 422 
and actin fibers regulate SSTR2 spatial arrangement and mobility and are required for coupling 423 
agonist-dependent SSTR2 clustering to its recruitment to CCPs and, ultimately, its 424 
internalization. These results, together with our previous observation that FLNA is involved in 425 
the regulation of SSTR2 signaling and downregulation (17), indicate FLNA as a novel potential 426 
target to modulate the amount of active SSTR2s at the plasma membrane, with possible 427 
implications for the therapy of pharmacologically resistant GH-secreting pituitary tumors.  428 
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Figure 1. 630 
 631 
Figure 1. Single-molecule visualization and tracking of individual SSTR2 and FLNA 632 
particles at the plasma membrane of living cells.  633 
(A and B) Schematic representation of the SNAP-SSTR2 (A) and CLIP-FLNA (B) constructs 634 
used in this study. (C-H) Single-molecule imaging. CHO cells were transfected with SNAP-635 
SSTR2 (C) or CLIP-FLNA (D), labeled with Alexa647-BG or TMR-Star-BC substrates, 636 
respectively, and imaged by TIRF microscopy. Shown are single frames of representative image 637 
sequences (C and D), the same with overlaid in blue the individual trajectories obtained with the 638 
automated tracking algorithm (E and F) and the trajectories alone (G and H). The current position 639 
of each particle is indicated by a blue circle. Scale bars, 10 µm. 640 
Figure 2. 641 
  642 
Figure 2. SSTR2 diffusion dynamics at the plasma membrane is modified by agonist 643 
stimulation.  644 
(A) MSD plots of representative SSTR2 trajectories classified into four groups based on their 645 
mobility. (B) Diffusion coefficient distribution of SSTR2 particles calculated from the MSD 646 
analysis and reported as percentage of total number of particles under basal (black) or stimulated 647 
condition (red).  (C) Frequency distributions of the trajectories in the four groups under basal and 648 
stimulated conditions. (D) Average diffusion coefficients of each group shown in (C). Differences 649 
in C and D are statistically significant by two-way ANOVA. *, P<0.05, ***, P<0.001 and ****, 650 
P<0.0001 vs. corresponding basal condition by Tukey’s multiple comparison test. (E) 651 
 31 
 Representative frame from a TIRF image sequence of SSTR2 particles (green) and actin fibers 652 
(magenta) in basal condition (left) and expanded view of the region marked with the yellow box 653 
(right). Arrowheads, individual SSTR2s localized along actin fibers. (F) Quantification of SSTR2 654 
colocalization with actin fibers under basal and stimulated conditions. **, P<0.01 vs. basal 655 
condition by unpaired t-test. All data are mean ± SEM of three independent experiments. 656 
Figure 3. 657 
 658 
Figure 3. SSTR2 interactions with FLNA and actin at the plasma membrane regulate 659 
SSTR2 mobility.  660 
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 (A) Top, selected frames from a representative TIRF image sequence acquired in CHO cells co-661 
expressing SNAP-SSTR2 (green), CLIP-FLNA (magenta) and LifeAct-GFP (blue). Bottom, 662 
corresponding trajectories showing an example of a SSTR2 transiently colocalizing with a FLNA 663 
molecule on an actin fiber (yellow). Scale bars, 1 µm. (B) Frequency distributions of the 664 
trajectories classified in the four mobility groups in the presence of FLNA17-18 or FLNA19-20 665 
fragments under both basal and stimulated conditions. (C) Average diffusion coefficients (D) 666 
corresponding to each group shown in (B). Differences in (B) and (C) are statistically significant 667 
by two-way ANOVA. *, P<0.05, **, P<0.01 and ***, P<0.001 by Tukey’s multiple comparison 668 
test vs. basal condition; ####, P<0.0001 by Tukey’s multiple comparison test vs. the 669 
corresponding fraction in the control (FLNA17-18). All data are mean ± SEM from three 670 
independent experiments. 671 
Figure 4. 672 
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  673 
Figure 4. Role of FLNA in agonist-dependent SSTR2 clustering.  674 
(A) Preferential alignment of SSTR2 clusters containing FLNA along actin fibers. CHO cells 675 
were transfected to express LifeAct-GFP (blue) together with single-molecule levels of SNAP-676 
SSTR2 (green) and CLIP-FLNA (magenta). Shown are representative average intensity 677 
projections of TIRF images sequences from three independent experiments under basal 678 
conditions (left) or after stimulation with BIM23120 for 10 min (middle). Arrowheads, SSTR2 679 
clusters containing FLNA aligned along actin fibers. Three examples of clusters are shown in 680 
expanded views (right). Scale bars, 10 μm. (B) Effect of disrupting SSTR2−FLNA interactions on 681 
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 the localization of SSTR2s along actin fibers. Shown are representative confocal optical sections 682 
showing the plasma membrane of CHO cells cotransfected with LifeAct-GFP (magenta), SNAP-683 
SSTR2 (green) and FLNA17-18 or FLNA19-20 fragments under basal or stimulated conditions. 684 
Insets, images showing high expression of the FLNA fragments. Arrowheads, SSTR2 clusters 685 
aligned along actin fibers. Scale bars, 10 μm. (C-E) Quantitative analyses of images like those 686 
shown in B. Reported are the Pearson’s correlation coefficient (PCC) between SNAP-SSTR2 and 687 
LifeAct-GFP images (C) as well as the number (D) and size (E) of SSTR2 clusters.**, P < 0.01 688 
and *, P < 0.05 vs. FLNA 17-18 transfected cells by unpaired Student’s t test. Data are mean ± 689 
SEM of 15 cells from three independent experiments.  690 
Figure 5. 691 
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  692 
Figure 5. FLNA is required for efficient SSTR2 recruitment to CCPs.  693 
(A) Effect of interfering with SSTR2−FLNA interactions on agonist-induced SSTR2 recruitment 694 
to CCPs. CHO cells were transiently cotransfected with SNAP-SSTR2 (green) and either FLNA 695 
17-18 or FLNA 19-20 (insets) and immunostained for AP-2 (magenta). Shown are representative 696 
confocal images acquired at the level of the plasma membrane (left) and expanded views of the 697 
regions marked with the yellow boxes (right). Arrowheads, SSTR2 clusters colocalizing with AP-698 
2 (white). Scale bars, 10 μm. (B) Quantitative analysis of images like those shown in A. The 699 
extent of pixel colocalization between SSTR2 and AP-2 is expressed as mean ± SEM of Manders’ 700 
colocalization coefficients (MCC) where MCC1 represents the fraction of SSTR2 overlapping 701 
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 with AP-2 and MCC2 the fraction of AP-2 overlapping with SSTR2 (Menders et al., 1993). For 702 
each condition, 15 cells from three independent experiments were analyzed. **, P<0.01 vs. 703 
FLNA 17-18 expressing cells by unpaired Student’s t test.  704 
Figure 6. 705 
 706 
Figure 6. Inhibition of FLNA-SSTR2 interactions affects agonist-mediated SSTR2 707 
internalization.   708 
(A) CHO cells coexpressing SNAP-SSTR2 (green) and either FLNA17-18 (top) or FLNA19-20 709 
(bottom) were incubated with 100 nM BIM23120 for 15, 30, and 60 min. Shown are 710 
representative confocal images acquired at the level of the nucleus. Hatched white lines represent 711 
the membrane area. Insets show the corresponding FLNA17-18 (top) or FLNA19-20 (bottom) 712 
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 images. DAPI (blue) was used to stain the nucleus. Scale bars, 5 μm. (B) Quantitative analysis of 713 
SSTR2 internalization based on confocal images like those in A. For each group, at least 30 cells 714 
from three independent experiments were analyzed. Data are mean ± SEM *, P<0.05 and **, 715 
P<0.01 vs. FLNA 17-18 expressing cells; §, P<0.05, §§, P<0.01, §§§, P<0.001 vs. respective 716 
basal condition by unpaired Student’s t test. (C) Quantification of SSTR2 internalization based on 717 
biotinylation of membrane receptors. CHO cells transiently cotransfected with FLNA 17-18 or 718 
FLNA 19-20 and wild-type SSTR2 were incubated with or without 100 nM BIM23120 for 30 719 
min. SSTR2 was immunoprecipitated with a specific antibody and the internalized biotinylated 720 
SSTR2 was detected with an antibody recognizing biotin. Shown are the mean ± SEM of three 721 
independent experiments. *, P<0.05 vs. FLNA17-18 transfected cells; §§, P<0.01 vs. 722 
corresponding basal condition by unpaired Student’s t test. 723 
Figure 7. 724 
 725 
Figure 7. Proposed model for FLNA role in SSTR2 diffusion dynamics and internalization.  726 
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 Under resting conditions, SSTR2s diffuse at the cell surface (1). Agonist binding (2) promotes 727 
FLNA recruitment to SSTR2s (3), which increases their interaction with actin fibers. This favors 728 
the formation of SSTR2 clusters and their correct localization in actin-rich regions of the plasma 729 
membrane (4). These events promote the recruitment of SSTR2s to CCPs (5) and, ultimately, 730 
their internalization (6).  731 
 732 
Supplementary Data 733 
 734 
Supplemental Figure 1.  735 
Functional characterization of SNAP-SSTR2 construct. HEK293A cells were co-transfected 736 
with SNAP-SSTR2 or wild-type SSTR2 and the FRET sensor for cAMP Epac1-camps. Cells 737 
were prestimulated with forskolin to activate adenylyl cyclases followed by incubation with 738 
increasing concentrations of the SSTR2-selective agonist BIM23120. The resulting inhibition of 739 
cAMP production was measured in real time by FRET microscopy. The SNAP-SSTR2 construct 740 
is fully functional, as shown by cAMP concentration-response dependencies comparable to those 741 
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 observed with wild-type SSTR2. Data are mean ± SEM of 10 cells from three independent 742 
experiments. 743 
 744 
Supplemental Figure 2.  745 
Validation of CLIP-FLNA construct. (A) TIRF images of CHO cells transfected with CLIP-746 
FLNA or eGFP-FLNA, respectively. The CLIP-FLNA construct displays a normal arrangement 747 
along stress fibers, similar to what observed with eGFP-FLNA. (B) TIRF images of CHO cell 748 
cotransfected with CLIP-FLNA (green) and LifeAct-GFP (magenta). The resulting merge image 749 
is shown. Colocalization between CLIP-FLNA and actin filaments was analyzed by NIH ImageJ 750 
software and is shown in white, confirming the actin-binding property of the CLIP-FLNA 751 
construct. Scale bars, 10 µm. 752 
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  753 
Supplemental Figure 3.  754 
Single-molecule visualization of SSTR2 colocalizing with FLNA and actin at the cell 755 
surface. A-C Further examples of images and corresponding trajectories from TIRF-M time-756 
lapse sequences acquired in three representative living CHO cells stained for actin (blue) and 757 
expressing single-molecule levels of SNAP-SSTR2 (green) and CLIP-FLNA (magenta), labeled 758 
with Alexa647-BG and TMR-BC dye, respectively. SSTR2 and FLNA trajectories are depicted 759 
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 in green and magenta, respectively, whilst SSTR2−FLNA apparent interactions are represented 760 
by yellow trajectories. Scale bars, 1 µm.  761 
Supplemental Video 1.  762 
SSTR2 and FLNA during an apparent interaction on underlying actin fiber. Shown are 763 
individual SSTR2 (green) and FLNA (magenta) particles undergoing transient interactions over 764 
an actin fiber (blue) in a living CHO cell. Frames were acquired every 61.9 ms. 765 
Supplemental Video 2.  766 
SSTR2 and FLNA trajectories. Corresponding trajectories of individual SSTR2 (green) and 767 
FLNA (magenta) particles shown in Movie S1. The trajectories are colored in yellow during the 768 
apparent interaction.  769 
 770 
 42 
